HeartWare Announces New 450 Person Trial for its Ventricular Assist System
Posted on May 9, 2012
A federal advisory panel recently recommended the approval of HeartWare's ventricular assist system. The advisory committee voted 9 to 2 that the benefits outweigh the risks for the use of the HeartWare Ventricular Assist System as a bridge to heart transplantation in patients with end-stage heart failure. HeartWare recently announced a new 450-patient clinical trial for the device. The system, which is implanted inside a patient, keeps a failing heart pumping while a patient is waiting for a heart transplant to become available.
NMA News created an animation showing how the VAD works. Take a look: